BERTOLI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 323
AS - Asia 93
EU - Europa 74
AF - Africa 4
Totale 494
Nazione #
US - Stati Uniti d'America 323
SG - Singapore 59
IT - Italia 31
VN - Vietnam 20
DE - Germania 14
IE - Irlanda 10
BE - Belgio 7
CN - Cina 5
IN - India 5
TG - Togo 4
FI - Finlandia 3
IR - Iran 3
RU - Federazione Russa 3
UA - Ucraina 3
CH - Svizzera 2
GB - Regno Unito 1
PH - Filippine 1
Totale 494
Città #
Chandler 61
Singapore 58
Ann Arbor 35
Ashburn 28
Dong Ket 20
Boardman 17
Seattle 17
Fairfield 15
Wilmington 13
Woodbridge 11
Dublin 10
Houston 10
Trieste 10
Brussels 7
Cambridge 6
Princeton 6
San Diego 6
Ogden 5
Lomé 4
New York 4
Redmond 4
Brugnera 3
Des Moines 3
Helsinki 3
Hyderabad 3
Munich 3
Beijing 2
Jacksonville 2
Los Angeles 2
Nanjing 2
Treviso 2
Udine 2
Washington 2
Zurich 2
Ardabil 1
Augusta 1
Dallas 1
Grafing 1
Hamburg 1
Leawood 1
Mortegliano 1
Nantong 1
Nuremberg 1
Padova 1
Redwood City 1
San Mateo 1
Santa Clara 1
Santa Maria 1
Totale 392
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 123
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 81
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 64
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 42
Find the flame: Predictive biomarkers for immunotherapy in melanoma 38
“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers 36
NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease 22
Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials 22
Chylous Ascites as a Possible Rare Side Effect of Selpercatinib in RET-Positive NSCLC 17
Acquired Resistance to Osimertinib in EGFR‐Mutated Non‐Small Cell Lung Cancer: How Do We Overcome It? 17
The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation 15
Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications 14
Brain Metastases Management in Oncogene‐Addicted Non‐Small Cell Lung Cancer in the Targeted Therapies Era 14
Targeted Therapy in Mesotheliomas: Uphill All the Way 10
Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer 9
Totale 524
Categoria #
all - tutte 3.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 0 0 13 15 3 4
2020/2021136 6 8 24 18 4 12 3 10 3 5 19 24
2021/202254 4 6 0 1 1 0 6 3 0 8 19 6
2022/2023131 9 15 5 13 15 39 0 12 11 4 4 4
2023/202477 6 6 7 1 15 14 1 2 8 9 2 6
2024/202591 18 19 13 14 27 0 0 0 0 0 0 0
Totale 524